Explore
Validate
Learn
Blocking/NeutralizingAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB805 - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human Osteoprotegerin/TNFRSF11B Monoclonal Antibody (Clone 69146)
- Antibody type
- Monoclonal
- Antigen
- S. frugiperda insect ovarian cell line Sf 21-derived recombinant human Osteoprotegerin/TNFRSF11B, Glu22-Leu401
- Description
- Protein A or G purified from ascites
- Reactivity
- Human
- Host
- Mouse
- Antigen sequence
AAB53709- Isotype
- IgG
- Vial size
- 500 µg
Submitted references Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis.
Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis.
Inflammatory cell infiltrate and RANKL/OPG expression in rheumatoid synovium: comparison with other inflammatory arthropathies and correlation with outcome.
Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
Locklin RM, Federici E, Espina B, Hulley PA, Russell RG, Edwards CM
Molecular cancer therapeutics 2007 Dec;6(12 Pt 1):3219-28
Molecular cancer therapeutics 2007 Dec;6(12 Pt 1):3219-28
Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis.
Makrygiannakis D, af Klint E, Catrina SB, Botusan IR, Klareskog E, Klareskog L, Ulfgren AK, Catrina AI
Arthritis and rheumatism 2006 May;54(5):1463-72
Arthritis and rheumatism 2006 May;54(5):1463-72
Inflammatory cell infiltrate and RANKL/OPG expression in rheumatoid synovium: comparison with other inflammatory arthropathies and correlation with outcome.
Fonseca JE, Cortez-Dias N, Francisco A, Sobral M, Canhão H, Resende C, Castelão W, Macieira C, Sequeira G, Saraiva F, da Silva JA, Carmo-Fonseca M, Viana Queiroz M
Clinical and experimental rheumatology 2005 Mar-Apr;23(2):185-92
Clinical and experimental rheumatology 2005 Mar-Apr;23(2):185-92
Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
Mandelin J, Li TF, Hukkanen M, Liljeström M, Salo J, Santavirta S, Konttinen YT
The Journal of rheumatology 2005 Apr;32(4):713-20
The Journal of rheumatology 2005 Apr;32(4):713-20
No comments: Submit comment
No validations: Submit validation data